Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Can grapefruit consumption affect lipitor's efficacy?Guselkumab patent expiration?What condition primarily benefits from sapropterin therapy?Dabrafenib patent expiration date novartis gsk composition matter?How does insurance coverage impact nivolumab's duration?
See the DrugPatentWatch profile for Zevalin
Zevalin (ibritumomab tiuxetan) is manufactured by Bristol Myers Squibb (BMS).
Zevalin’s manufacturer has been Bristol Myers Squibb; product availability and distribution can vary by country even when the manufacturer is the same.
To verify the manufacturer for the exact product you’re looking at, check the package insert or labeling for your local market. Those documents list the current manufacturer and marketing authorization holder for that region.
Other Questions About Zevalin :